392 related articles for article (PubMed ID: 18317762)
1. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
[TBL] [Abstract][Full Text] [Related]
2. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
Ali BH; Al Moundhri MS
Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin: a review of toxicities and therapeutic applications.
Barabas K; Milner R; Lurie D; Adin C
Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
[TBL] [Abstract][Full Text] [Related]
4. [Can cisplatin renal toxicity be prevented?].
Brillet G; Deray G; Bunker D; Ben Hmida M; Baumelou A; Jacobs C
Nephrologie; 1991; 12(3):143-6. PubMed ID: 1922654
[TBL] [Abstract][Full Text] [Related]
5. [About side effects of platinum drugs].
Waszkiewicz K
Postepy Hig Med Dosw; 2001; 55(3):387-406. PubMed ID: 11505639
[TBL] [Abstract][Full Text] [Related]
6. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
[TBL] [Abstract][Full Text] [Related]
7. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
Hayek M; Srinivasan A
Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
[No Abstract] [Full Text] [Related]
8. [Renal complications of anti-cancer chemotherapy].
Fillastre JP; Moulin B; Godin M; Josse S
Pathol Biol (Paris); 1986 Nov; 34(9):1013-28. PubMed ID: 3543812
[TBL] [Abstract][Full Text] [Related]
9. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
Goligorsky MS
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
[No Abstract] [Full Text] [Related]
10. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Dana R; Kachhwaha VS
Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of common drugs used by urologists.
Bennett WM; Porter GA
Urol Clin North Am; 1990 Feb; 17(1):145-56. PubMed ID: 2407013
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of cancer treatment.
Lydon J
Oncol Nurs Forum; 1986; 13(2):68-77. PubMed ID: 3633578
[No Abstract] [Full Text] [Related]
13. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
14. [Anticancer drugs used in medicine and being in clinical research].
Malinowska K; Modranka R; Kedziora J
Pol Merkur Lekarski; 2007 Sep; 23(135):165-9. PubMed ID: 18080687
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity from chemotherapy: prevention and management.
Vogelzang NJ
Oncology (Williston Park); 1991 Oct; 5(10):97-102, 105; disc. 105, 109-11. PubMed ID: 1838278
[TBL] [Abstract][Full Text] [Related]
16. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
Chirino YI; Pedraza-Chaverri J
Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].
Gestin-Boyer C; René C; Cupissol D; Tep A; Bressolle F; Bres J; Brun S; Serrou B; Pujol H
C R Seances Soc Biol Fil; 1989; 183(3):263-8. PubMed ID: 2532561
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of cytotoxics-platinum agents.
Selvaratnam G; Philips RH; Mohamed AK; Radzi A
Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
[No Abstract] [Full Text] [Related]
19. [Prevention and management of nephrotoxicity from anti-cancer agents].
Miyazaki J; Kawai K
Nihon Rinsho; 2003 Jun; 61(6):973-7. PubMed ID: 12806945
[TBL] [Abstract][Full Text] [Related]
20. Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.
Lyubimova NV; Topchieva SV; Averinova SG; Kashkadaeva AV; Gorbunova VA; Shiryaev SV; Kushlinskii NE
Bull Exp Biol Med; 2000 Sep; 130(9):886-91. PubMed ID: 11177273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]